These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31794197)

  • 1. Solvent-Induced Protein Precipitation for Drug Target Discovery on the Proteomic Scale.
    Zhang X; Wang Q; Li Y; Ruan C; Wang S; Hu L; Ye M
    Anal Chem; 2020 Jan; 92(1):1363-1371. PubMed ID: 31794197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solvent-Induced Protein Precipitation for Drug Target Discovery.
    Zhang X; Hu L; Ye M
    Methods Mol Biol; 2023; 2554():35-45. PubMed ID: 36178619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advances in protein precipitation-based methods for drug-target screening].
    Liu T; Qin WJ; Yang HJ
    Se Pu; 2024 Jul; 42(7):613-622. PubMed ID: 38966970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solvent-induced proteome profiling for proteomic quantitation and target discovery of small molecular drugs.
    Yu C; Chen X; Xu W; Li S; Chai Q; Zhang Y
    Proteomics; 2023 Jun; 23(12):e2200281. PubMed ID: 36843329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib, imatinib and staurosporine capture compounds - Complementary tools for the profiling of kinases by Capture Compound Mass Spectrometry (CCMS).
    Fischer JJ; Dalhoff C; Schrey AK; Graebner OY; Michaelis S; Andrich K; Glinski M; Kroll F; Sefkow M; Dreger M; Koester H
    J Proteomics; 2011 Dec; 75(1):160-8. PubMed ID: 21664307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Targeted Quantitative Analysis of the Interaction between HSP90 and Kinases.
    Miao W; Li L; Wang Y
    Anal Chem; 2019 Sep; 91(18):11507-11509. PubMed ID: 31476117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and optimization of a series of 2-aminothiazole-oxazoles as potent phosphoinositide 3-kinase γ inhibitors.
    Oka Y; Yabuuchi T; Fujii Y; Ohtake H; Wakahara S; Matsumoto K; Endo M; Tamura Y; Sekiguchi Y
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7534-8. PubMed ID: 23122859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamic Analysis of the Geldanamycin-Hsp90 Interaction in a Whole Cell Lysate Using a Mass Spectrometry-Based Proteomics Approach.
    Xu Y; Wallace MA; Fitzgerald MC
    J Am Soc Mass Spectrom; 2016 Oct; 27(10):1670-6. PubMed ID: 27530778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90.
    Fadden P; Huang KH; Veal JM; Steed PM; Barabasz AF; Foley B; Hu M; Partridge JM; Rice J; Scott A; Dubois LG; Freed TA; Silinski MA; Barta TE; Hughes PF; Ommen A; Ma W; Smith ED; Spangenberg AW; Eaves J; Hanson GJ; Hinkley L; Jenks M; Lewis M; Otto J; Pronk GJ; Verleysen K; Haystead TA; Hall SE
    Chem Biol; 2010 Jul; 17(7):686-94. PubMed ID: 20659681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based proteome profiling of potential dasatinib targets by use of affinity-based probes.
    Shi H; Zhang CJ; Chen GY; Yao SQ
    J Am Chem Soc; 2012 Feb; 134(6):3001-14. PubMed ID: 22242683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90.
    Riccardi Sirtori F; Caronni D; Colombo M; Dalvit C; Paolucci M; Regazzoni L; Visco C; Fogliatto G
    Eur J Pharm Sci; 2015 Aug; 76():83-94. PubMed ID: 25952103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonists.
    Epple R; Cow C; Xie Y; Azimioara M; Russo R; Wang X; Wityak J; Karanewsky DS; Tuntland T; Nguyêñ-Trân VT; Cuc Ngo C; Huang D; Saez E; Spalding T; Gerken A; Iskandar M; Seidel HM; Tian SS
    J Med Chem; 2010 Jan; 53(1):77-105. PubMed ID: 19928766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical stress induced protein precipitation method for drug target screening.
    Lyu J; Wang Y; Ruan C; Zhang X; Li K; Ye M
    Anal Chim Acta; 2021 Jul; 1168():338612. PubMed ID: 34051997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.
    Kumalo HM; Bhakat S; Soliman ME
    Chem Biol Drug Des; 2015 Nov; 86(5):1131-60. PubMed ID: 25958815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of HSP90 as a direct target of artemisinin for its anti-inflammatory activity via quantitative chemical proteomics.
    Wu G; Cheng B; Qian H; Ma S; Chen Q
    Org Biomol Chem; 2019 Jul; 17(28):6854-6859. PubMed ID: 31263819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical proteomics-driven discovery of oleocanthal as an Hsp90 inhibitor.
    Margarucci L; Monti MC; Cassiano C; Mozzicafreddo M; Angeletti M; Riccio R; Tosco A; Casapullo A
    Chem Commun (Camb); 2013 Jul; 49(52):5844-6. PubMed ID: 23703283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical Denaturation and Protein Precipitation Approach for Discovery and Quantitation of Protein-Drug Interactions.
    Meng H; Ma R; Fitzgerald MC
    Anal Chem; 2018 Aug; 90(15):9249-9255. PubMed ID: 29995387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target identification of natural and traditional medicines with quantitative chemical proteomics approaches.
    Wang J; Gao L; Lee YM; Kalesh KA; Ong YS; Lim J; Jee JE; Sun H; Lee SS; Hua ZC; Lin Q
    Pharmacol Ther; 2016 Jun; 162():10-22. PubMed ID: 26808165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proteomic snapshot of the human heat shock protein 90 interactome.
    Falsone SF; Gesslbauer B; Tirk F; Piccinini AM; Kungl AJ
    FEBS Lett; 2005 Nov; 579(28):6350-4. PubMed ID: 16263121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative proteomics reveals molecular mechanism of gamabufotalin and its potential inhibition on Hsp90 in lung cancer.
    Zhang L; Yu Z; Wang Y; Wang X; Zhang L; Wang C; Yue Q; Wang X; Deng S; Huo X; Tian X; Huang S; Zhang B; Ma X
    Oncotarget; 2016 Nov; 7(47):76551-76564. PubMed ID: 27384878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.